1. Home
  2. Shareholder and Investor Information
  3. Disclaimer

Shareholder and Investor Information

Disclaimer

Regarding the Use of IR Information

The IR information posted on this website is intended to provide financial information and management indicators, and are not expressions or guarantees concerning the content. In addition, the information contained in this website is not intended to solicit investment. When making an actual investment, investors should not base their decisions entirely on the information found in this website and should make decisions based on investors' own judgment.

The Information Posted

RaQualia has given the utmost care to the accuracy of the information posted on this website; however, RaQualia is not responsible for any errors in the information, misrepresentations in data provided by third parties, harm caused by downloads, or any other problems.

Regarding Outlooks for the Future

Some of the information posted on this website includes content about future business performance. This content does not guarantee future business performance and takes into account risk and uncertainty. Please be aware that future performance can be affected by changes in the business environment and actual results may be different from predictions.

Using this Website

This website may be suspended or ceased without notice, and content may be changed. Further, there may be times when the website cannot be used normally due to problems in the communication network, or the customer's computer system, or for other reasons. RaQualia seeks your understanding in advance that we are not responsible for any difficulties, losses, or damages that arise due to these kinds of circumstances.

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics